George W. Lloyd, EVP, Investments & CLO at Royalty Pharma plc (RPRX), sold 50,000 shares at $37.27 ($1.9M) on 2023-02-23, disclosed to the SEC on 2023-02-27.
Open-market sale of $1.9M RPRX by EVP, Investments & CLO. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Something here stands out, but not much.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $37.27 | 25,000 | $932K | 50.0% |
| 2 | $37.27 | 25,000 | $932K | 50.0% |
| Total | $37.27 avg | 50,000 | $1.9M | 100% |
| Filing → |
| RPRX | SELL | 2025-11-21 | $10.4M | — | Filing → |
| RPRX | SELL | 2023-06-06 | $13.0M | — | Filing → |
| RPRX | SELL | 2023-03-30 | $4.7M | — | Filing → |